Johns Hopkins Medicine: Study finds switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV European AIDS Treatment Group
Serwis informacyjny, platforma współpracy grupowej, szkolenia i egzaminy
Johns Hopkins Medicine: Study finds switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV European AIDS Treatment Group